These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1203 related items for PubMed ID: 17557887

  • 1. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 3. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 4. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.
    Liu SD, Lee S, La Cava A, Motran CC, Hahn BH, Miceli MC.
    Lupus; 2011 Apr; 20(5):473-84. PubMed ID: 21335401
    [Abstract] [Full Text] [Related]

  • 5. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H, Weill B, Fournier C, Batteux F.
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [Abstract] [Full Text] [Related]

  • 6. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F, Hahn BH, Rizzi M, Anderson M, Fitzgerald J, Millo E, Indiveri F, Shi FD, Filaci G, La Cava A.
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [Abstract] [Full Text] [Related]

  • 7. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB.
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [Abstract] [Full Text] [Related]

  • 8. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
    Bahjat FR, Pine PR, Reitsma A, Cassafer G, Baluom M, Grillo S, Chang B, Zhao FF, Payan DG, Grossbard EB, Daikh DI.
    Arthritis Rheum; 2008 May; 58(5):1433-44. PubMed ID: 18438845
    [Abstract] [Full Text] [Related]

  • 9. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 May; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice.
    Hentati B, Sato MN, Payelle-Brogard B, Avrameas S, Ternynck T.
    Eur J Immunol; 1994 Jan; 24(1):8-15. PubMed ID: 8020574
    [Abstract] [Full Text] [Related]

  • 11. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
    Wang X, Huang W, Schiffer LE, Mihara M, Akkerman A, Hiromatsu K, Davidson A.
    Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
    [Abstract] [Full Text] [Related]

  • 12. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis.
    Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G.
    Eur J Immunol; 1995 Jan; 25(1):6-12. PubMed ID: 7843255
    [Abstract] [Full Text] [Related]

  • 13. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B, Wu J, Chu YW, Wang Y, Wang DP, Wu HS, Xiong SD.
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [Abstract] [Full Text] [Related]

  • 14. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP.
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [Abstract] [Full Text] [Related]

  • 15. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
    Starke C, Steinkasserer A, Voll RE, Zinser E.
    Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
    [Abstract] [Full Text] [Related]

  • 16. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, Putterman C.
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [Abstract] [Full Text] [Related]

  • 17. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 18. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.
    Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW.
    Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982
    [Abstract] [Full Text] [Related]

  • 19. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
    Margaritte C, Gilbert D, Brard F, Tron F.
    J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
    [Abstract] [Full Text] [Related]

  • 20. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D, Gattorno M, Casazza S, Uccelli A, Moretta L, Martini A, Traggiai E.
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.